In one study, two types of siRNA (against prostatic cancer cells with overexpression of PLK-1 and luciferase genes) were conjugated to the cyclodextrin to prepare cyclodextrin-based delivery systems, in which the conjugation was done based on applying two types of non-cleavable and cleavable linkers. This evidence concerns the gene PLK1 and prostate carcinoma.